INTRODUCTION
The link between coagulation and innate immunity can be traced back to the early stages of evolution. In invertebrate species, a single cell type, the hemocyte, performs the functions of both clotting and inflammation. 1 The basic elements of clotting and inflammation have diverged in vertebrates into the platelets, neutrophils, monocytes and antigen-presenting cells, yet the evolutionary link between clotting and innate immunity remains evident in human physiology.
Humoral and cellular elements of the innate immune system (pattern recognition receptor molecules such as Toll-like receptors, CD14, the alternative complement pathway, mannose binding lectins, along with neutrophils, monocyte/macrophage cell lines, NK cells) comprise the early responders in the host defense against microbial infection. The clotting system is almost always called into action in response to systemic microbial invasion as seen in patients with septic shock. 2 The simultaneous activation of the inflammatory and clotting networks following tissue injury is a phylogenetically ancient survival strategy. The innate immune system recognizes highly conserved structures found within members of the Archea and Bacteria kingdoms but not found in multicellular eukaryotic organisms. 3 Molecules such as lipopolysaccharide, bacterial flagellin, peptidoglycan and unmethylated CpG motifs of bacterial DNA are unique to prokaryotic organisms. 4 The ability to discern non-self molecules rapidly from self-molecules has an obvious survival advantage and serves as the fundamental molecular basis for the innate immune response to microbial pathogens. 5 Many of these same inflammatory signals precipitate procoagulant signals. Components of the coagulation system feed back and rapidly up-regulate innate immune responses. This collaboration between clotting and inflammation accounts for the basic survival approach of walling off the damaged and infected tissues from the rest of the host while the endogenous antimicrobial systems of the innate immune system attempt to eliminate the microbial invaders.
The administration of recombinant human activated protein C (rhAPC) improves the outcome of patients with severe sepsis. 10 Importantly, this anticoagulant also significantly reduced circulating interleukin-6 (IL-6) levels, a commonly measured inflammatory biomarker in septic patients. This indicates that the deleterious systemic inflammatory response seen in septic shock can be modulated by an anticoagulant. Multiple anti-inflammatory agents have failed to improve the mortality rate in clinical trials for human sepsis, yet the anticoagulant approach with rhAPC was successful. Either blockade of clotting is essential for the reduced systemic inflammation in sepsis or rhAPC possesses both anti-coagulant and anti-inflammatory properties critical to improve the outcome in human sepsis. 9, 10 
METHODS
The data presented in this selective, brief review are derived for a literature review of the relevant publications found in the English literature relating to interactions between coagulation and inflammation. A Medline search over the past 25 years was used with the search words: 'coagulation', 'inflammation', 'anticoagulants' and 'fibrinolysis'.
RESULTS AND DISCUSSION

Functional and structural homologies between coagulation and the innate immune system
Many of the coagulation and inflammatory molecules in humans share structural homologies attesting to their common ancestral origin (e.g. tissue factor homology with cytokine receptors).
Functional similarities exist as well. Pattern recognition molecules of the innate immune system function in a manner similar to that of the contact factors of the intrinsic clotting system. 15 The contact factors of the clotting system (factors XII, XI and high molecular weight kininogen) initiate clot formation following exposure to foreign surfaces (i.e. catheter materials, prosthetic devices) and highly negatively charged molecules (i.e. phospholipids, lipopolysaccharide [LPS]). The pattern recognition molecules of the innate immune defense system recognize surface features of microbial pathogens that differ from human cell membranes. 3, 4 This results in the generation of a network of early host response signals that alarms the host defenses to the presence of a potential microbial threat. 12 Presumably in response to selection pressures exerted upon our early hominid ancestors, humans possess an 126 Opal Fig. 1 . The major coagulation factors and the network of regulatory signals that contribute to coagulation activation in sepsis. TF, tissue factor; APC, activated protein C; TFPI, tissue factor pathway inhibitor; t-PA, tissue type plasminogen activator; PAI-1, plasminogen activator inhibitor-1. Solid arrows represent activation pathways in the coagulation cascades and open arrows indicate inhibitory pathways. exquisitely sensitive and vigorous immune and clotting response to microbial challenge. 1, 12 Recent advances in medicine over the past century in industrialised countries (e.g. public health, antimicrobial agents, immunizations, improved surgical techniques, and innovations in supportive care units) have significantly altered the balance between long-term survival and the propensity of humans to induce inflammation and clotting rapidly. Human populations in much of Europe, North America and developed parts of Asia are now experiencing dramatic increases in the incidence of chronic inflammatory (Crohn's disease, asthma), thrombotic (myocardial infarction, stroke) and immune-mediated disorders (i.e. type 1 diabetes mellitus, multiple sclerosis) while infectious diseases have become less prevalent in modern societies. 13, 14 Major elements of the human coagulation system
The major clotting elements responsible for the procoagulant effects of severe infection and septic shock are found in Figure 1 . The extrinsic pathway (tissue factor pathway) is the primary mechanism by which thrombin is generated in sepsis. Tissue factor expression is upregulated on monocytes/macrophages and to a limited extent on endothelial cells following the release of inflammatory mediators such as endotoxin, C-reactive protein, IL-1 and IL-6. 1, 2, 15 Tissue factor expressed within the intravascular space will bind to circulating factor VII resulting in a tissue factor:FVIIa complex. TF:FVIIa complexes can directly activate the common pathway of coagulation by converting factor X to factor Xa. Factor Xa in the presence of factor Va forms a prothrombin-converting complex resulting in thrombin formation and the subsequent generation of a fibrin clot. 1 The intrinsic clotting system (contact factor pathway) principally serves an accessory role by amplifying the clotting process once initiated in sepsis (see Fig. 1 ). TNF up-regulates tissue-type (intravascular space) and urokinase-type (extravascular space) plasminogen activator 15 which rapidly activates the fibrinolytic system. Fibrinolysis is then rapidly inhibited by PAI-1 (plasminogen activator inhibitor-1) in the intravascular space and PAI-2 in the extravascular space.
Thrombin, 16 factor Xa 17 and tissue factor:factor VIIa complex 15 can directly activate endothelial cells, platelets and white blood cells via a series of specific receptors known as protease-activated receptors (PARs). Thus, intravascular coagulation induces a pro-inflammatory response. 18, 19 The inflammatory reaction to tissue injury activates the clotting system, inhibits the endogenous anticoagulants, and attenuates the fibrinolytic response. The net effect within the microcirculation is a combined and selfperpetuating, procoagulant and pro-inflammatory state that has major therapeutic implications. 7, 8, 11 The endogenous anticoagulants and their anti-inflammatory actions There are four major systems that limit fibrin formation in the circulation. These include: (i) antithrombin; (ii) tissue factor pathway inhibitor; (iii) the protein C: protein S:thrombomodulin pathway; and (iv) the fibri- 1, 20 Increases prostacyclin synthesis by endothelial cells, limits cytokine synthesis and leukocyte adherence; inhibits chemotaxis of neutrophils and monocytes TFPI activity 9, 21 Down-regulation of cytokine synthesis within microcirculation Fibrinolytic system 2, 5 Fibrinolysis removes a fibrin mesh for neutrophil and monocyte adherence; prevents hypoperfusion and ischemia-reperfusion injury PAR, protease activated receptor; TFPI, tissue factor pathway inhibitor; EPCR, endothelial protein C receptor; PAR-1, protease activated receptor-1; TM, thrombomodulin; MAP, mitogen-activated protein; NF-kB, nuclear factor kappa B. nolytic system. Depletion or inhibition of these systems contributes to the consumptive coagulopathy of sepsis and promotes the on-going inflammatory response. 1, 2 Their major anti-inflammatory properties are described in Table 1 . [20] [21] [22] [23] [24] [25] 
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Cross talk between and the co-regulation of inflammation and coagulation
Inflammation promotes coagulation at multiple levels within the clotting and fibrinolytic system ( Table 2) . A number of pro-inflammatory cytokines, particularly IL-6, increase the expression of tissue factor on monocytes and possibly on endothelial cell surfaces. 15 Tumor necrosis factor (TNF) and IL-1b alter the expression of multiple anticoagulant factors and inhibit fibrinolytic pathways. 1, 2, 8, 19, 26 Conversely, generalized procoagulant activity induces potent inflammatory signals throughout the microcirculation (Table 3 ). The convergence of coagulation and innate immunity contributes to the pathogenesis of septic shock. 5, 26, 27 
CONCLUSIONS
The coagulation system and the innate immune system evolved together to defend the host from loss of internal integrity and microbial invasion following injury. The simultaneous and disordered activation of both systems in the face of generalized infection culminates in a deleterious state of diffuse clotting and systemic inflammation that typifies septic shock. The survival benefits derived from the use of rhAPC in sepsis indicate that the injurious molecular events found in human sepsis are potentially reversible.
128 Opal Platelet activation 26, 27 Secretion of chemokines, PAF and IL-1b; platelet-derived P-selectin promotes neutrophil adherence; platelet CD40 ligand promotes endothelial cell chemokine and adhesion molecule expression.
Fibrin deposition 1,2 Neutrophil and monocyte adherence; decreased capillary perfusion induces ischemia-reperfusion injury to tissues PAR, protease-activated receptor; MCP-1, monocyte chemo-attractant peptide-1; PAF, platelet activating factor.
Advances in the understanding of the control elements of generalized inflammation and disordered coagulation may provide new approaches in the treatment of septic shock.
